Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)
A Contract Award Notice
by UK HEALTH SECURITY AGENCY
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 4 year
- Value
- £1
- Sector
- HEALTH
- Published
- 29 Aug 2025
- Delivery
- 01 Oct 2025 to 30 Sep 2029
- Deadline
- 10 Mar 2025 13:00
Concepts
Location
Geochart for 1 buyers and 2 suppliers
1 buyer
- UK Health Security Agency London
2 suppliers
- Merck Sharpe & Dohme London
- Glaxosmithkline London
Description
Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this procurement. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Award Detail
1 | Merck Sharpe & Dohme (London)
|
2 | Glaxosmithkline (London)
|
CPV Codes
- 33651600 - Vaccines
Other Information
Award documents MMRV Award documents MMRV.zip
Reference
- CF-3099100D0O000000rwimUAA
- CF 104b2cd5-fb74-454c-b381-334a14f4a40a